258
-3
9
Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Browse Other Projects on Experiment
Related Projects
Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection
We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...
Gila monster genomics: conservation, venom, and treatments for Type-II diabetes
The Gila monster, with its distinctive black and orange pattern, is one of Arizona’s most iconic animals...
Can we noninvasively measure blood sugar for diabetes?
Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better...